(Q36040118)

11 August 2017

1 reference

title

The diagnosis and therapy of tuberculosis during the past 100 years (English)

1 reference

11 August 2017

0 references

Denis A Mitchison

1

1 reference

PubMed ID

15709048

11 August 2017

language of work or name

English

0 references

publication date

11 February 2005

1 reference

American Journal of Respiratory and Critical Care Medicine

11 August 2017

1 reference

11 August 2017

171

1 reference

11 August 2017

699-706

1 reference

11 August 2017

7

1 reference

Computed tomography features of acute pulmonary tuberculosis

11 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1603OE

Ending the routine guinea-pig test

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1603OE

STREPTOMYCIN treatment of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1603OE

The problem of self-administration of drugs; with particular reference to pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1603OE

Laboratory aspects of intermittent drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1603OE

The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1603OE

Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1603OE

The action of antituberculosis drugs in short-course chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1603OE

Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1603OE

Recent developments in the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1603OE

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1603OE

Microbiology. TB--a new target, a new drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1603OE

The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1603OE

The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1603OE

Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1603OE

Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1603OE

Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200411-1603OE

10.1164/RCCM.200411-1603OE

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15709048